Compounds > 4-hydroxybutyric acid
Page last updated: 2024-08-21

4-hydroxybutyric acid and Acquired Metabolic Diseases, Brain

4-hydroxybutyric acid has been researched along with Acquired Metabolic Diseases, Brain in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamaguchi, S1
Boenzi, S; Carducci, C; Deodato, F; Di Sabato, ML; Dionisi-Vici, C; Leuzzi, V; Liberanome, C; Malaspina, P; Rizzo, C1

Reviews

1 review(s) available for 4-hydroxybutyric acid and Acquired Metabolic Diseases, Brain

ArticleYear
[Organic acid disorders: cerebral organic acidemia].
    Ryoikibetsu shokogun shirizu, 2002, Issue:37 Pt 6

    Topics: Brain Diseases, Metabolic; Canavan Disease; Glutarates; Glycerol; Humans; Hydroxybutyrates; Infant; Infant, Newborn; Intellectual Disability; Metabolism, Inborn Errors; Mevalonic Acid; Pyrrolidonecarboxylic Acid; Seizures

2002

Other Studies

1 other study(ies) available for 4-hydroxybutyric acid and Acquired Metabolic Diseases, Brain

ArticleYear
Vigabatrin improves paroxysmal dystonia in succinic semialdehyde dehydrogenase deficiency.
    Neurology, 2007, Apr-17, Volume: 68, Issue:16

    Topics: Adolescent; Brain; Brain Diseases, Metabolic; Dystonic Disorders; Epilepsy; Extremities; GABA Agents; gamma-Aminobutyric Acid; Gene Expression Regulation, Enzymologic; Humans; Hydroxybutyrates; Intellectual Disability; Italy; Male; Muscle, Skeletal; Mutation, Missense; Succinate-Semialdehyde Dehydrogenase; Treatment Outcome; Vigabatrin

2007